These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 13532082)

  • 21. Pharmacology of the central nervous system.
    Shellenberger MK; Walaszek EJ
    Prog Neurol Psychiatry; 1972; 27():67-86. PubMed ID: 4145416
    [No Abstract]   [Full Text] [Related]  

  • 22. Unsurmountable antagonism of brain 5-hydroxytryptamine2 receptors by (+)-lysergic acid diethylamide and bromo-lysergic acid diethylamide.
    Burris KD; Sanders-Bush E
    Mol Pharmacol; 1992 Nov; 42(5):826-30. PubMed ID: 1359397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An experimental study of the participation of the sympathetic nervous system in the lysergic acid diethylamide (LSD) reaction in cats.
    ELDER JT; DILLE JM
    J Pharmacol Exp Ther; 1962 May; 136():162-8. PubMed ID: 13889792
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of LSD on the central nervous system (review)].
    Popova EN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(3):457-62. PubMed ID: 4978646
    [No Abstract]   [Full Text] [Related]  

  • 25. A central nervous system effect of a nonhallucinatory lysergic acid derivative.
    SPIRTES MA; GUTH PS; POLLEY EH
    Experientia; 1958 Nov; 14(11):428. PubMed ID: 13609622
    [No Abstract]   [Full Text] [Related]  

  • 26. LSD and CNS transmission.
    Aghajanian GK
    Annu Rev Pharmacol; 1972; 12():157-68. PubMed ID: 4339014
    [No Abstract]   [Full Text] [Related]  

  • 27. The inhibition of human brain acetylcholinesterase by LSD-25 and JB-336 in vitro.
    Bajgar J; Patocka J; Zizkovský V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1971; 14(4):417-23. PubMed ID: 5291385
    [No Abstract]   [Full Text] [Related]  

  • 28. Some in vitro effects of chlorpromazine, lysergic acid diethylamide, and 5-hydroxytryptamine on the respiration of rat brain.
    STARBUCK WC; HEIM HC
    J Am Pharm Assoc Am Pharm Assoc; 1959 Apr; 48(4):251-3. PubMed ID: 13641067
    [No Abstract]   [Full Text] [Related]  

  • 29. Some CNS electrophysiologic effects of serotonin and lysergic acid diethylamide.
    GUNN CG
    Psychiatr Res Rep Am Psychiatr Assoc; 1960 Jan; 12():194-203. PubMed ID: 13851827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of diethylamide of 3-methoxy-4-hydroxybenzoic acid on respiration and blood circulation].
    AUINGER W; KAINDL F; SALZMANN F; WEISSEL W
    Wien Z Inn Med; 1952 Jan; 33(1):23-31. PubMed ID: 14922891
    [No Abstract]   [Full Text] [Related]  

  • 31. Lysergic acid diethylamide: dissociation of its behavioral and hyperthermic actions by DL-alpha-methyl-p-tyrosine.
    Horita A; Hamilton AE
    Science; 1969 Apr; 164(3875):78-9. PubMed ID: 5773714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Protective action of lysergic acid ethylamide (LAE-32) on behavior changes & on histological lesions of the central nervous system induced in mice by chronic treatment with 5-hydroxytryptamine].
    SORIANI S; FAVALE E
    Sist Nerv; 1959; 11(1):13-21. PubMed ID: 13659105
    [No Abstract]   [Full Text] [Related]  

  • 33. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the mechanism of lysergic acid diethylamide (LSD) action on the central nervous system].
    Anokhina IP
    Fiziol Zh SSSR Im I M Sechenova; 1967 Sep; 53(9):1016-25. PubMed ID: 5615978
    [No Abstract]   [Full Text] [Related]  

  • 36. The CNS action of d-lysergic acid diethylamide (L.S.D.-25).
    SMITH R
    Mod Hosp; 1953 Jan; 80(1):106-10. PubMed ID: 13025280
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effect of LSD on reaction times in a conditioned avoidance reaction and in the analgesia test].
    TAESCHLER M; WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1960; 18():43-9. PubMed ID: 13836568
    [No Abstract]   [Full Text] [Related]  

  • 38. Drugs that antagonize limb flick behavior induced by D-lysergic acid diethylamide (LSD) in cats.
    Haigler HJ; Spring DD
    Psychopharmacology (Berl); 1979 Jun; 64(1):31-4. PubMed ID: 113828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on a new analeptic agent, centphenaquin (11-(N4-phenylpiperazine)-7,8,9,10-tetrahydro-6H-cyclohepta [b]quinoline dihydrochloride): Part I. Analysis of respiratory stimulant action.
    Patnaik GK; Anand N; Dhawan BN
    Indian J Exp Biol; 1985 Apr; 23(4):208-13. PubMed ID: 2867030
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.